ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹44.7 Cr (+22.8% YoY) and net profit of ₹1.6 Cr (+220.0% YoY) for Q2 FY27.
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹36.9 Cr (+64.7% YoY) and net profit of ₹1.2 Cr (+1100.0% YoY) for Q1 FY27.
Novelix Pharmaceuticals reported a total annual revenue of ₹132.34 Crore and net profit of ₹2.56 Crore for FY26. The results received an unmodified audit opinion.
Novelix Pharmaceuticals approved audited FY2026 financial results and received ₹0.42 Crore from warrant conversions. Revenue reached ₹132.34 Crore with a net profit of ₹2.56 Crore.
Novelix Pharmaceuticals Ltd reported net profit of ₹1 Cr (+900.0% YoY) for Q3 FY26.